Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
$11.31
+0.0%
$11.30
$10.65
$11.62
$699.02M0.01409,692 shs205,189 shs
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
$10.80
$10.80
$10.05
$11.68
$209.10M0.01122,781 shs5,636 shs
CION Investment Corporation stock logo
CION
CION Investment
$9.25
+0.2%
$9.52
$8.51
$12.71
$486.30M1.12267,175 shs707,208 shs
CNCK
Coincheck Group
$5.20
+0.4%
$6.29
$4.22
$14.42
$671.85M0.0777,198 shs149,393 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
+0.09%+0.09%+0.27%+1.03%+6.15%
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
0.00%0.00%0.00%-0.05%-0.05%
CION Investment Corporation stock logo
CION
CION Investment
+0.22%+2.04%-3.24%-14.75%-25.20%
CNCK
Coincheck Group
+0.39%+4.00%-13.48%-13.91%+519,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
N/AN/AN/AN/AN/AN/AN/AN/A
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
CION Investment Corporation stock logo
CION
CION Investment
1.3907 of 5 stars
1.83.01.70.01.51.70.6
CNCK
Coincheck Group
1.4883 of 5 stars
3.50.00.00.01.11.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
0.00
N/AN/AN/A
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
0.00
N/AN/AN/A
CION Investment Corporation stock logo
CION
CION Investment
1.50
Reduce$11.0018.98% Upside
CNCK
Coincheck Group
3.00
Buy$10.0092.31% Upside

Current Analyst Ratings Breakdown

Latest BIOS, AACT, CNCK, and CION Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/28/2025
CION Investment Corporation stock logo
CION
CION Investment
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$10.00 ➝ $9.00
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
N/AN/A$0.42 per share27.18($0.35) per shareN/A
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/AN/AN/AN/A
CION Investment Corporation stock logo
CION
CION Investment
$252.43M1.93$1.91 per share4.85$15.40 per share0.60
CNCK
Coincheck Group
$2.56B0.26N/AN/A$0.55 per share9.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
$25.99MN/A0.00N/AN/A-101.04%4.12%8/4/2025 (Estimated)
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
CION Investment Corporation stock logo
CION
CION Investment
$33.90M-$0.29N/A6.85N/A-6.49%10.07%4.28%8/6/2025 (Estimated)
CNCK
Coincheck Group
-$95.70MN/A0.00N/AN/A-359.24%-4.64%N/A

Latest BIOS, AACT, CNCK, and CION Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
CION Investment Corporation stock logo
CION
CION Investment
$0.37$0.36-$0.01-$0.80$54.15 million$56.07 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
N/AN/AN/AN/AN/A
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/AN/AN/A
CION Investment Corporation stock logo
CION
CION Investment
$1.4415.58%N/AN/A 1 Years
CNCK
Coincheck Group
N/AN/AN/AN/AN/A

Latest BIOS, AACT, CNCK, and CION Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2025
CION Investment Corporation stock logo
CION
CION Investment
quarterly$0.3615.2%6/2/20256/2/20256/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
N/A
0.24
0.24
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/AN/AN/A
CION Investment Corporation stock logo
CION
CION Investment
N/A
0.04
0.04
CNCK
Coincheck Group
N/A
1.07
1.01

Institutional Ownership

CompanyInstitutional Ownership
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
72.95%
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
66.19%
CION Investment Corporation stock logo
CION
CION Investment
32.01%
CNCK
Coincheck Group
33.22%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ares Acquisition Corporation II stock logo
AACT
Ares Acquisition Corporation II
N/A61.86 millionN/ANot Optionable
BioPlus Acquisition Corp. stock logo
BIOS
BioPlus Acquisition
N/A19.37 million14.99 millionNot Optionable
CION Investment Corporation stock logo
CION
CION Investment
N/A52.69 million52.39 millionOptionable
CNCK
Coincheck Group
N/A129.70 million45.27 millionN/A

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Ares Acquisition Corporation II stock logo

Ares Acquisition Corporation II NYSE:AACT

$11.30 +0.01 (+0.04%)
Closing price 06/20/2025 03:57 PM Eastern
Extended Trading
$11.28 -0.03 (-0.22%)
As of 06/20/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ares Acquisition Corp. II is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on March 15, 2021 and is headquartered in New York, NY.

BioPlus Acquisition stock logo

BioPlus Acquisition NASDAQ:BIOS

BioPlus Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. BioPlus Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

CION Investment stock logo

CION Investment NYSE:CION

$9.24 +0.02 (+0.16%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$9.16 -0.08 (-0.87%)
As of 06/20/2025 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CION Investment Corporation is a business development company. It specializes in investments in senior secured loans, including unitranche loans, First Lien, second lien loans, long-term subordinated loans, and mezzanine loans; equity interests such as warrants or options; and corporate bonds; and other debt securities in middle-market companies. The firm invests in growth capital, acquisitions, leveraged buyouts, market/product expansion, refinancing and recapitalization. The fund also invests up to 30 percent of their assets opportunistically in other types of investments, including the securities of larger public companies and foreign securities. It also makes investments in the secondary loan market. The fund does not invest in start-up companies, turnaround situations, or companies with speculative business plans. The fund prefers to invest in high tech industries, healthcare, pharmaceuticals, business services, media, chemicals, plastic, rubber, telecommunication, consumer services, advertising, printing and publishing, consumer goods, durables, diversified financials, and other industries. It also invests in homebuilding, restaurants, beverage and tobacco bars, broadcasting, distributors, Non-durable good distribution, food beverage and tobacco, energy, oil gas and consumables fuels, insurance, aerospace and defense, industrial machinery, paper and forest product machinery, information technology, metals and mining, and real estate. It primarily seeks to invest in the United States. The fund seeks to invest between $5 million and $50 million in companies with an EBITDA between $25 million and $75 million with average targeted hold of $25 million. It also purchases minority interests in the form of common or preferred equity in the target companies, typically in conjunction with its debt investments or through a co-investment with a financial sponsor. The fund seeks to exit its investments through an initial public offering of common stock, a merger, a sale, or other recapitalization.

Coincheck Group NASDAQ:CNCK

$5.20 +0.02 (+0.39%)
As of 06/20/2025 04:00 PM Eastern

Coincheck Group NV. is a Dutch public limited liability company and a holding company of Coincheck, Inc. which operates one of the largest multi-cryptocurrency marketplaces and crypto asset exchanges in Japan and is regulated by the Financial Services Agency of Japan. The company was founded on February 18, 2022 and is headquartered in Amsterdam, Netherland.